Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.52% Nasdaq Down1.11%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM

7.88 May 22, 4:00PM EDT|Pre-Market : 7.84 Down 0.04 (0.51%) 8:43AM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue -   5,000   -  
Cost of Revenue -   -   -  
Gross Profit -   5,000   -  
Operating Expenses
Research Development19,369  26,209  13,728  
Selling General and Administrative7,710  7,540  7,487  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (27,079) (28,749) (21,215)
Income from Continuing Operations
Total Other Income/Expenses Net4,358  380  764  
Earnings Before Interest And Taxes(25,360)(28,369)(20,451)
Interest Expense -   -   -  
Income Before Tax(25,360)(28,369)(20,451)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(25,360)(28,369)(20,451)
Non-recurring Events
Discontinued Operations -  246  120  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (22,721) (28,123) (20,331)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (22,721) (28,123) (20,331)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.